Open Label Study of KRN23 on Osteomalacia in Adults With X-linked Hypophosphatemia (XLH)

PHASE3CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

December 23, 2015

Primary Completion Date

August 30, 2017

Study Completion Date

December 13, 2018

Conditions
X-linked Hypophosphatemia
Interventions
BIOLOGICAL

burosumab

solution for subcutaneous injection

Trial Locations (14)

8000

Aarhus University Hospital-Dept of Endocrinology and Internal Medicine, Aarhus

27710

Duke University Medical Center, Durham

46202

Indiana University Department of Medicine University Hospital, Indianapolis

75014

CHU Paris Centre - Hôpital Cochin, Paris

77030

Houston Methodist Hospital, Houston

94158

UCSF Medical Center at Mission, San Francisco

94275

CHU de Bicêtre, Service d'Endocrinologie et des Maladies de la Reproduction, Le Kremlin-Bicêtre

06510

Yale University School of Medicine - Yale New-Haven Hospital/Yale Center for Clinical Investigation, New Haven

K1H 8L1

Children's Hospital of Eastern Ontario, Ottawa

H3G 1A6

Shriners Hospital for Children, Montreal

565-0871

Osaka University Hospital, Osaka

060-8648

Hokkaido University Hospital, Sapporo

113-8655

The University of Tokyo Hospital, Tokyo

110-744

Seoul National University Hospital, Seoul

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Kyowa Kirin Co., Ltd.

INDUSTRY

lead

Kyowa Kirin, Inc.

INDUSTRY